Project: Monitoring and early diagnosis of graft rejection by highly sensitive NGS analysis of cfDNA in blood

Acronym	ENVISAGE (Reference Number: 114787)
Duration	01/01/2021 - 01/01/2024
Project Topic	In ENVISAGE, we will develop and clinically validate an NGS-based, high throughput and high-accuracy assay for measurement of donor-derived cell-free DNA (ddcfDNA) in kidney transplant patients to monitor graft integrity and identify early risk of rejection when it can still be hampered. The new assay will be a IVD registered product bundle consisting on a ready to use NGS library preparation kit of reagents, optimized protocols and a dedicated software for data collection and analysis.
Network	Eurostars 2
Call	Eurostars Cut–off 14

Project partner

Number	Name	Role	Country
1	DEVYSER AB	Coordinator	Sweden
2	University of Zurich	Partner	Switzerland